A founder I once watched present to a board had two slides for the same growth target. Slide one: hire twelve people, open one new region a year, hit the number in four years. Slide two: buy a competitor and hit it in nine months. The room loved slide two. It almost always does, and that is exactly where the trouble starts.

The quick version

  • Organic growth expands the business with its own engine, more customers, new products, new markets, better operations. It is cheaper and lower-risk, but slow.
  • Inorganic growth adds scale or capability by buying or merging with another company. It is fast, but expensive, and most of the value leaks away in integration.
  • The M&A failure rate sits between 70% and 90% across decades of studies. Acquisition is a real tool, not a shortcut around hard work.
  • The pattern that wins is rarely either/or: a healthy organic core plus a disciplined, repeatable acquisition habit tends to beat both pure strategies.

The idea in depth

Start with the plainest possible definition, because the jargon hides a simple idea. Organic growth is growth you generate from inside the business: selling more to existing customers, winning new ones, launching new products, entering new markets, or squeezing more output from the same operation. Inorganic growth is growth you acquire from outside, by buying another company, merging, or taking a controlling stake. One is built; the other is bought.

The cleanest map of the organic options is also one of the oldest. In 1957, the mathematician-turned-strategist H. Igor Ansoff published "Strategies for Diversification" in Harvard Business Review, laying out what became the Ansoff growth-vector matrix. He plotted growth on two axes, products (existing or new) and markets (existing or new), producing four moves: sell more of what you have to who you have (market penetration), take existing products to new markets, build new products for current customers, or do both at once (diversification). His core point still holds: the further you travel from what you already know on either axis, the more risk you take on. Penetration is the safe corner; diversification is the cliff edge.

So the move is: before anyone says "let's acquire," map your honest organic options on Ansoff's grid first. Most teams have unworked penetration and product-development potential sitting right under them, cheaper and safer than any deal. If the organic corners are genuinely tapped, you have earned the right to look outside.

flowchart LR
	A(["Want to grow"]) --> B{"Can the core engine deliver it in time?"}
	B -->|"Yes"| C(["Organic: penetrate, build, expand markets"])
	B -->|"No, missing capability, scale or time"| D{"Clear on WHY we're buying?"}
	D -->|"No"| C
	D -->|"Yes"| E(["Inorganic: acquire or merge"])
	C --> F(["Reinvest profits into the core"])
	E --> F
Build-or-buy as one decision, not two camps. Leaders Loop

Why the "just buy it" instinct misfires

The attraction of inorganic growth is real: an acquisition can hand you a customer base, a product, a geography or an engineering team overnight, years of organic slog, compressed into a signing. The problem is the bill, and the gap between what you pay for and what you actually keep.

The single most useful number to carry into any deal conversation comes from the late Clayton Christensen and colleagues, writing in HBR in 2011: "The Big Idea: The New M&A Playbook." "Study after study," they note, "puts the failure rate of mergers and acquisitions somewhere between 70% and 90%." Companies spend trillions a year on deals, and the majority destroy value. The usual autopsy blames overpaying, thin due diligence and clumsy integration, all true. But Christensen's deeper argument is the one worth internalising: most acquirers never get clear on why they are buying, so they price and integrate the deal the wrong way for its purpose. He splits acquisitions into two kinds, buying to improve your current business (cheaper, faster, more of the same) versus buying to reinvent it (a new growth engine), and shows that the two demand completely different prices and completely different post-deal handling. Confuse them and you overpay for the first or smother the second.

So the move is: before you value a target, write one sentence, "we are buying this to ___." If the blank is "improve and extend what we already do well," integrate it tightly and wring out the cost savings. If it is "enter a game we can't play yet," leave it alone, protect its model, and resist the urge to fold it into the mothership. The sentence determines the deal.

"Study after study puts the failure rate of mergers and acquisitions somewhere between 70% and 90%.", Christensen et al., HBR, 2011

An honest limitation: that 70–90% figure is repeated everywhere and rarely defined the same way twice. "Failure" can mean lost shareholder value, missed synergy targets, or eventual divestiture, and the studies use different windows and samples. Read it as a strong directional warning, not a precise probability. The signal holds even if the decimal places don't: acquisitions disappoint far more often than boardrooms assume.

The case for a strong core, and for buying well

If acquisition is so risky, why not grow purely organically? Because the evidence doesn't reward purity either, it rewards discipline. Bain's Chris Zook and James Allen, in Profit from the Core, studied the growth histories of thousands of companies and found the most durable growth comes from a strong, well-led core business that is continually reinvested in, then extended through "adjacency" moves, steps into territory next to what you already do best, which carry far less risk than outright diversification. Their lesson cuts both ways: get everything out of the core before you reach further, and when you do reach, reach into the adjacent, not the alien.

On the inorganic side, the most encouraging research says the winners aren't the boldest dealmakers but the most repetitive ones. McKinsey's long-running work on what it calls "programmatic" M&A, a steady stream of small, deliberate, theme-driven deals rather than one transformational "big bang", finds that programmatic acquirers tend to outperform their industry peers on excess total shareholder return, while companies that lean hardest on single large deals fare worst, and companies that avoid M&A entirely often lag too. The skill isn't the heroic acquisition; it's the boring, repeatable acquisition habit.

So the move is: if you're going to grow inorganically, build a muscle, not a moment. A pipeline of small, on-strategy, adjacent deals you can integrate in your sleep will almost always beat the one transformational acquisition that bets the company. Practise on deals you can afford to get wrong.

An honest limitation: both findings are correlational. Programmatic acquirers may outperform partly because they were already healthy, disciplined organisations, not purely because of the deal cadence. Treat "do lots of small deals" as a pattern strong performers share, not a guarantee that copying the pattern makes you one.

quadrantChart
	title Ansoff's growth grid, organic moves by risk
	x-axis "Existing market" --> "New market"
	y-axis "Existing product" --> "New product"
	quadrant-1 "Diversification (riskiest)"
	quadrant-2 "Product development"
	quadrant-3 "Market penetration (safest)"
	quadrant-4 "Market development"
The four organic growth moves; risk rises as you leave the bottom-left. After Ansoff (1957). Leaders Loop

A worked example

Picture a profitable UK software firm, call it Northgate, selling scheduling tools to dental practices. The board wants to double revenue in three years. (All figures below are illustrative.)

The organic path: Northgate is in about 15% of UK dental practices. Market penetration alone, better sales coverage, a tighter onboarding, a referral nudge, could plausibly lift that to 25% over three years at a cost of, say, £1.2m in salespeople and product. Slow, dull, and almost certainly value-creating.

The inorganic path: a competitor in veterinary scheduling is for sale at £9m. It would add revenue overnight and open a new vertical. Tempting. But applying the one-sentence test, Northgate's reason is "enter a game we can't play yet", a reinvention deal, not an improvement deal. That means it should be priced cautiously and run at arm's length, not crushed into the dental org chart on day one. Northgate's mistake-in-waiting is to pay an "improvement" price, then fire the vet team's salespeople to capture "synergies," and watch the very capability it bought walk out the door.

The disciplined answer is rarely either slide. Northgate works the organic penetration hard (cheap, certain), and pursues one small, adjacent tuck-in, a two-person team that already built a dental-payments add-on, for £600k, integrating it tightly because it genuinely is "more of what we do well." Build the core, buy the adjacency, leave the moonshot for when the balance sheet can absorb a miss.

Frequently asked questions

Is organic or inorganic growth better?

Neither, universally. Organic growth is cheaper, lower-risk and proves real demand, but it is slow. Inorganic growth buys time, scale or a missing capability, but it is costly and most of the value leaks out in integration. The strongest performers run both: a healthy organic core plus a disciplined, repeatable acquisition habit.

Why do so many acquisitions fail?

Studies put the M&A failure rate between 70% and 90%. The visible causes are overpaying, weak due diligence and botched integration. The deeper one, per Christensen, is buying for an unclear reason and then pricing and integrating the deal the wrong way for that reason.

What's the difference between a merger and organic growth?

Organic growth expands the business using its own resources, more customers, new products, new markets, better operations. A merger or acquisition is inorganic: you add revenue, customers or capability by combining with or buying another company instead of building it yourself.

Can a small company grow inorganically?

Yes. Acquisition isn't only for giants. Small firms routinely buy a competitor, a supplier or a small team to gain a capability faster than they could hire it. The discipline is identical at any size: be clear why you're buying, don't overpay, and plan the integration before you sign.

How do I know when my organic options are tapped?

Map them on Ansoff's grid and be honest. If penetration and product development still have obvious, fundable room, your organic engine isn't exhausted, it's under-fed. Look outside only when the cheaper corners are genuinely worked.

Related in the Toolkit

Where to go next